Active monitoring, radical prostatectomy, or radiotherapy for localised prostate cancer: study design and diagnostic and baseline results of the ProtecT randomised phase 3 trial.

@article{Lane2014ActiveMR,
  title={Active monitoring, radical prostatectomy, or radiotherapy for localised prostate cancer: study design and diagnostic and baseline results of the ProtecT randomised phase 3 trial.},
  author={J Athene Lane and Jenny L Donovan and Michael Davis and Eleanor I. Walsh and Daniel Dedman and Liz Down and Emma L. Turner and Malcolm David Mason and Chris Metcalfe and Tim J. Peters and Richard M Martin and David E. Neal and Freddie C. Hamdy},
  journal={The Lancet. Oncology},
  year={2014},
  volume={15 10},
  pages={
          1109-18
        }
}
BACKGROUND Prostate cancer is a major public health problem with considerable uncertainties about the effectiveness of population screening and treatment options. We report the study design, participant sociodemographic and clinical characteristics, and the initial results of the testing and diagnostic phase of the Prostate testing for cancer and Treatment (ProtecT) trial, which aims to investigate the effectiveness of treatments for localised prostate cancer. METHODS In this randomised phase… CONTINUE READING

Citations

Publications citing this paper.
SHOWING 1-10 OF 99 CITATIONS, ESTIMATED 45% COVERAGE

The Treatment of Localized Prostate Cancer in Everyday Practice in Germany.

VIEW 12 EXCERPTS
CITES BACKGROUND, METHODS & RESULTS
HIGHLY INFLUENCED

Studien zum lokal begrenzten Niedrigrisikoprostatakarzinom

VIEW 3 EXCERPTS
CITES BACKGROUND
HIGHLY INFLUENCED

Circulating Metabolic Biomarkers of Screen-Detected Prostate Cancer in the ProtecT Study.

  • Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology
  • 2019

FILTER CITATIONS BY YEAR

2014
2019

CITATION STATISTICS

  • 5 Highly Influenced Citations

  • Averaged 12 Citations per year from 2017 through 2019

References

Publications referenced by this paper.
SHOWING 1-10 OF 34 REFERENCES

A causal proportional hazards estimator for the e ff ect of treatment actually received in a randomized trial with allornothing compliance

T Loeys, E Goetghebeur
  • Stat Med
  • 2012